India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

Nektar Therapeutics completes target enrollment in REZOLVE-AD phase 2b trial of rezpegaldesleukin in patients with moderate-to-severe atopic dermatitis

Join Pharma | Login

	Editorial


	MAKE HOSPITALS A SAFER PLACE
	Wednesday, January 8, 2025
	Delhi Chief Minister Atishi has triggered a debate over the need for framing laws for the protection of healthcare professionals, especially the doctors. Addressing the Annual Conference of the Delhi State Medical Association recently
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Nektar Therapeutics completes target enrollment in REZOLVE-AD phase 2b trial of rezpegaldesleukin in patients with moderate-to-severe atopic dermatitis
17:00 [IST]	Qiagen increases QIAcuity Digital PCR High-Order Multiplexing capabilities to gain deeper insights from biological samples
16:40 [IST]	Lupin introduces Minzoya in US market
16:30 [IST]	Crinetics Pharma reports positive results from phase 2 trial of atumelnant in congenital adrenal hyperplasia
16:00 [IST]	NIHR-funded research shows AI may help doctors improve the success rates of IVF treatment
15:00 [IST]	ProMIS Neurosciences begins PRECISE-AD phase 1b trial of lead therapeutic candidate, PMN310 in Alzheimer’s disease

more news >>

TOP NEWS


08:00 [IST]	Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing
08:00 [IST]	KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes
08:00 [IST]	Exporters concerned over delay in getting relief under Section 43B(h) of IT Act
08:00 [IST]	MP DCA forms team of regulatory officers to assist pharma units in upgrading plants as per revised Schedule M
08:00 [IST]	Allowing separate timelines for large units and MSMES may create two categories of manufacturing facilities: Experts
08:00 [IST]	SMPMA urges govt to drop conditions mandated for extension of revised Schedule M implementation

more news >>

YESTERDAY'S NEWS


18:00 [IST]	CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis
17:00 [IST]	FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025
16:00 [IST]	Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea
15:00 [IST]	SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart
14:00 [IST]	Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
13:30 [IST]	Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market

more news >>

INTERVIEW


Molbio Diagnostics redefines molecular diagnostics with Truenat
Shiva Sriram, President of Molbio Diagnostics

Past Interviews...

	What's New?

Clopidogrel 75mg And Aspirin 75mg Tab Atorvastatin 10 Mg +aspirin 75 Mg (plain/delayed Release). Insulin Degludec And Aspart 100 Iu/ml-3 Ml (ryzodeg Flex Touch Pen) Clindamycin 100 Mg + Clotrimazole 200 Mg + Tinidazole 100 Mg (vaginal) Citicoline 500 Mg + Piracetam 400 Mg

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers